Xiang Yubo, Yang Yingxin, Liu Jia, Yang Xu
Department of Rehabilitation Medicine, General Hospital of Northern Theater Command, Shenyang, China.
Front Oncol. 2023 Jun 19;13:1219211. doi: 10.3389/fonc.2023.1219211. eCollection 2023.
Osteosarcoma (OS) is a primary malignant bone tumor that occurs in children and adolescents, and the PI3K/AKT pathway is overactivated in most OS patients. MicroRNAs (miRNAs) are highly conserved endogenous non-protein-coding RNAs that can regulate gene expression by repressing mRNA translation or degrading mRNA. MiRNAs are enriched in the PI3K/AKT pathway, and aberrant PI3K/AKT pathway activation is involved in the development of osteosarcoma. There is increasing evidence that miRNAs can regulate the biological functions of cells by regulating the PI3K/AKT pathway. MiRNA/PI3K/AKT axis can regulate the expression of osteosarcoma-related genes and then regulate cancer progression. MiRNA expression associated with PI3K/AKT pathway is also clearly associated with many clinical features. In addition, PI3K/AKT pathway-associated miRNAs are potential biomarkers for osteosarcoma diagnosis, treatment and prognostic assessment. This article reviews recent research advances on the role and clinical application of PI3K/AKT pathway and miRNA/PI3K/AKT axis in the development of osteosarcoma.
骨肉瘤(OS)是一种发生于儿童和青少年的原发性恶性骨肿瘤,在大多数骨肉瘤患者中PI3K/AKT通路过度激活。微小RNA(miRNA)是高度保守的内源性非蛋白质编码RNA,可通过抑制mRNA翻译或降解mRNA来调控基因表达。miRNA在PI3K/AKT通路中富集,PI3K/AKT通路的异常激活参与骨肉瘤的发生发展。越来越多的证据表明,miRNA可通过调控PI3K/AKT通路来调节细胞的生物学功能。miRNA/PI3K/AKT轴可调控骨肉瘤相关基因的表达,进而调节癌症进展。与PI3K/AKT通路相关的miRNA表达也与许多临床特征明显相关。此外,与PI3K/AKT通路相关的miRNA是骨肉瘤诊断、治疗和预后评估的潜在生物标志物。本文综述了PI3K/AKT通路及miRNA/PI3K/AKT轴在骨肉瘤发生发展中的作用及临床应用的最新研究进展。